MAIA Biotechnology | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Data insights

10 April 2025

MAIA throws more money at ateganosine

The THIO-104 study listing is live, along with questions about funding the trial.

Conferences Trial results

4 November 2024

SITC 2024 preview – late-breakers for Marengo and Indapta

Subscribe to MAIA Biotechnology